FDA NDC Directory · JSON-LD · Markdown

Liraglutide

NDC 0143-9144 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameliraglutide
Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215503
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsLIRAGLUTIDE (6 mg/mL)
Marketing started20241224
Package count2

External sources

Source: openFDA. Public-domain (CC0).